Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Gastric Cancer

Free Subscription 15.12.2025 2 BMC Cancer 4 BMC Gastroenterol 1 Cancer 1 Cancer Lett 1 Clin Res Hepatol Gastroenterol 4 Eur J Surg Oncol 2 Gut 1 Int J Oncol 2 J Clin Oncol 1 J Pathol 1 J Surg Oncol 1 Oncology 1 PLoS One 3 Surgery

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. YU S, Sun Y, Zhou J, Sun C, et al
   Dynamic CEA kinetics as a prognostic biomarker for HER2-negative advanced gastric cancer treated with chemoimmunotherapy.
   BMC Cancer. 2025;25:1857.
   PubMed         Abstract available
   
   
2. WU J, Yi Y, Wang Q, Qiao J, et al
   5-Hydroxytryptamine receptor 1D overexpression exacerbates gastric cancer proliferation, invasion, and angiogenesis by activating the Wnt/beta-catenin signaling.
   BMC Cancer. 2025 Dec 11. doi: 10.1186/s12885-025-15423.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

3. KANG YH, Chen RS, Hu Q, Sun HT, et al
   Clinical significance of the S204 phosphorylation of the Smad3 protein in combination with Ki67 for the metastasis and prognosis of gastric cancer.
   BMC Gastroenterol. 2025 Dec 12. doi: 10.1186/s12876-025-04485.
   PubMed         Abstract available
   
   
4. CHENG X, Zhang Y, Li X, Xu Z, et al
   Relationship of D-dimer with survival and metastasis in gastric cancer patients: a meta-analysis and systematic review.
   BMC Gastroenterol. 2025 Dec 11. doi: 10.1186/s12876-025-04532.
   PubMed         Abstract available
   
   
5. XU M, Liu D, Zhang M, Liu S, et al
   Changes of bone, adipose, and muscle-related body compositions in gastric cancers after gastrectomy using deep learning based automatic segmentation.
   BMC Gastroenterol. 2025 Dec 10. doi: 10.1186/s12876-025-04530.
   PubMed         Abstract available
   
   
6. ISSIN G, Demir F, Cagatay DV, Bakkaloglu IG, et al
   Macroscopic growth patterns and their molecular implications in gastric carcinoma: toward risk stratification via borrmann classification.
   BMC Gastroenterol. 2025 Dec 9. doi: 10.1186/s12876-025-04544.
   PubMed         Abstract available
   
   

   
   Cancer

7. KARUKONDA P, Czito BG, Duffy E, Uronis HE, et al
   Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED): A single-arm phase 2 trial.
   Cancer. 2025;131:e70213.
   PubMed         Abstract available
   
   

   
   Cancer Lett

8. KANG S, Seol D, Lee J, Bang C, et al
   Extrachromosomal DNA amplifications exhibit distinct molecular characteristics and prognostic implications in gastric cancer.
   Cancer Lett. 2025 Dec 9:218214. doi: 10.1016/j.canlet.2025.218214.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

9. LIU Z, Wang Y, Hong J, He F, et al
   Do serum biomarkers correlate to the risk of gastric lesions in patients with autoimmune gastritis?-A systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2025;49:102722.
   PubMed         Abstract available
   
   

   
   Eur J Surg Oncol

10. XU R, Li Y, Zhao H, Wang Z, et al
    Treating a single tumor deposits as two lymph node metastases can improve the accuracy of gastric cancer prognosis assessment.
    Eur J Surg Oncol. 2025;52:111351.
    PubMed         Abstract available
    
    
11. LI J, Lin X, Yin H, Bei T, et al
    Corrigendum to "Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study" [Eur. J. Surg. Oncol. 51 (2025) 110548].
    Eur J Surg Oncol. 2025;52:111336.
    PubMed        
    
    
12. WANG X, Wu T, Zhang X, Jin P, et al
    Optimal artificial intelligence model based on gastrointestinal filling contrast-enhanced ultrasound: Risk stratification of gastric gastrointestinal stromal tumors.
    Eur J Surg Oncol. 2026;52:111190.
    PubMed         Abstract available
    
    
13. CAO Y, Jin T, Chen Z, Du E, et al
    The association between pathological complete response and prognosis of gastric or adenocarcinoma of esophagogastric junction cancer following neoadjuvant chemotherapy: A meta-analysis.
    Eur J Surg Oncol. 2026;52:110528.
    PubMed         Abstract available
    
    

    
    Gut

14. BANG JY, Puri R, Lakhtakia S, Thakkar S, et al
    Endoscopic or surgical gastroenterostomy for malignant gastric outlet obstruction: a randomised trial.
    Gut. 2025;75:24-32.
    PubMed         Abstract available
    
    
15. KIM H, Kim J, Jeong IH, Park E, et al
    Hybrid identity and distinct methylation profiles of incomplete intestinal metaplasia in the stomach.
    Gut. 2025;75:10-23.
    PubMed         Abstract available
    
    

    
    Int J Oncol

16. MA J, Zhan T, Zhang X, Gao W, et al
    Roles of interleukins in spasmolytic polypeptide?expressing metaplasia (Review).
    Int J Oncol. 2026;68:17.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

17. SHITARA K
    Reply to: Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015.
    J Clin Oncol. 2025 Dec 11:JCO2502148. doi: 10.1200/JCO-25-02148.
    PubMed        
    
    
18. JIANG Z, Xiang Y, Yi B
    Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015.
    J Clin Oncol. 2025 Dec 11:JCO2502049. doi: 10.1200/JCO-25-02049.
    PubMed        
    
    

    
    J Pathol

19. SHI M, Yang H, Zhang F, Hou T, et al
    Molecular evidence of a clonal relationship of synchronous/multifocal gastric-type lesions of the female genital tract.
    J Pathol. 2026;268:27-39.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

20. ZHANG Y
    Severe Complications in Remnant Gastric Cancer: An Epiphenomenon of Tumor Biology and Surgical Complexity?
    J Surg Oncol. 2025 Dec 9. doi: 10.1002/jso.70165.
    PubMed        
    
    

    
    Oncology

21. OYA S, Sato Y, Asaoka R, Sugawara K, et al
    Lymphatic Metastasis Predicts Better Response to Nivolumab in Recurrent or Metastatic Gastric Cancer: Insights from Tumor-Draining Lymph Node Immunity and Long-Term Outcomes.
    Oncology. 2025 Dec 4:1-17. doi: 10.1159/000549852.
    PubMed         Abstract available
    
    

    
    PLoS One

22. YANG X, Chen S, Zhong C, Lai Y, et al
    Trend analysis and projection of gastric cancer burden linked to high sodium intake in China, Japan, Republic of Korea, and Mongolia (1990-2021): A comprehensive assessment based on the 2021 global burden of disease study.
    PLoS One. 2025;20:e0338030.
    PubMed         Abstract available
    
    

    
    Surgery

23. LIU F, Xu Y, Wu H, Chen W, et al
    Short-term and long-term efficacy of laparoscopic D2 lymphadenectomy combined with complete mesogastrium excision for locally advanced upper gastric cancer.
    Surgery. 2025 Dec 8:109932. doi: 10.1016/j.surg.2025.109932.
    PubMed         Abstract available
    
    
24. YAN S, Li Z, Zhang S, Wu Z, et al
    Postoperative infectious complications in gastric and colorectal cancer patients: A multicenter prospective cohort study from China.
    Surgery. 2026;189:109780.
    PubMed         Abstract available
    
    
25. MICHELAKOS T, Tobias J, Abou Azar S, Polite B, et al
    Evaluating the role of postoperative long-acting somatostatin analog therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking.
    Surgery. 2026;189:109762.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.